ARKG vs. PBPH
ARKG (ARK Genomic Revolution Multi-Sector ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds. ARKG is actively managed, while PBPH is passively managed. At a 0.42 correlation, their price movements are largely independent. ARKG charges 0.75%/yr vs 0.13%/yr for PBPH.
Performance
ARKG vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKG achieves a 17.09% return, which is significantly higher than PBPH's -1.13% return.
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARKG vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | -6.97% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between ARKG and PBPH is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.42 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. PBPH — Risk / Return Rank
ARKG
PBPH
ARKG vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARKG | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.22 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.95 | — | — |
| Martin ratioReturn relative to average drawdown | 4.67 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARKG | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | -0.04 | +0.18 |
Drawdowns
ARKG vs. PBPH - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for ARKG and PBPH.
Loading charts...
Drawdown Indicators
| ARKG | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | -11.10% | -72.49% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | — | — |
Current DrawdownCurrent decline from peak | -69.65% | -8.69% | -60.96% |
Average DrawdownAverage peak-to-trough decline | -35.87% | -4.23% | -31.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.46% | — | — |
Volatility
ARKG vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| ARKG | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.90% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 28.77% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 41.12% | 16.78% | +24.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.61% | 16.78% | +28.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.12% | 16.78% | +24.34% |
ARKG vs. PBPH - Expense Ratio Comparison
ARKG has a 0.75% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
ARKG vs. PBPH - Dividend Comparison
ARKG has not paid dividends to shareholders, while PBPH's dividend yield for the trailing twelve months is around 0.09%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ARKG and PBPH have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.75% for ARKG.
PBPH has the higher dividend yield at 0.09%, compared with 0.00% for ARKG.
They also come from different issuers: ARK and Portfolio Building Block. Their fees differ too: 0.75% for ARKG and 0.13% for PBPH.
Find the right allocation for ARKG and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer